Zobrazeno 1 - 10
of 31
pro vyhledávání: '"V Boerlin"'
Autor:
R. Tanaka, A. Beck, A. D. Christ, M. Meyer, Y. Takano, Ulrich Beyer, Takashi Kadowaki, S. Ikeda, V. Boerlin, C. Ciorciaro, O. Cynshi
Publikováno v:
Diabetes, obesitymetabolism. 17(10)
Aim To assess the efficacy, safety and tolerability of different doses of tofogliflozin, a novel, highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes mellitus (T2DM). Methods In a 12-week, multicentre,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37488b62956e5e7fdc246484bf4d4fca
https://pubmed.ncbi.nlm.nih.gov/26179482
https://pubmed.ncbi.nlm.nih.gov/26179482
Autor:
Susan M. Webb, B. Charbonnel, Christiane Ajzenberg, Brigitte Delemer, Werner A. Scherbaum, R Santen, F Jockenhoevel, Ph. Caron, L Foubert, H Prestele, Y. Bachelot, C. Cortet, Pedro J. Benito, Varela C, V Boerlin, Jean-Marc Kuhn, Patrick Roger, J Leclere, E. Torres, F Escobar-Jiménez, Sonia Gaztambide, J Bringer, L Perlemuter, Vincent Rohmer, Geneviève Sassolas, Y Lorcy, F Villamil, Philippe Chanson, Jochen Schopohl
Publikováno v:
Clinical Endocrinology. 53:577-586
BACKGROUND AND OBJECTIVE The most effective option for the medical treatment of patients with acromegaly is the use of somatostatin analogues. Long-acting depot formulations for intramuscular injection of two somatostatin analogues have recently beco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91d8e937804a79b43465b968266d93ce
https://doi.org/10.1046/j.1365-2265.2000.01134.x
https://doi.org/10.1046/j.1365-2265.2000.01134.x
Autor:
V. Boerlin, H. G. Haas, U. Trechsel, Markus J. Seibel, Marius E. Kraenzlin, C. A. Kraenzlin, M. Azria
Publikováno v:
Calcified Tissue International. 58:216-220
Although treatment with intranasal salmon calcitonin (sCT) has been shown to effectively inhibit postmenopausal bone loss, there is still controversy over both timing and the duration of its application. In an open prospective study, we therefore ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e8abf23d9ea2d678a512b0f981428e
https://doi.org/10.1007/bf02508638
https://doi.org/10.1007/bf02508638
Autor:
A, Colao, D, Ferone, P, Marzullo, P, Cappabianca, S, Cirillo, V, Boerlin, I, Lancranjan, G, Lombardi
The effects of a 12- to 24-month treatment with depot long-acting octreotide (OCT-LAR) on hormone profile, tumor mass, and clinical symptoms were reported in 36 patients with active acromegaly [GH, 34.2 +/- 5.6 microg/L; insulin-like growth factor I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f33a9585c9266fbf4e30be616517eb41
http://hdl.handle.net/11588/133968
http://hdl.handle.net/11588/133968
Autor:
V, Boerlin, J, van der Hoek, Ch, Beglinger, K W, Poon, S, Hartmann, C, Dutreix, J M, Kovarik, Ch, Bruns, G, Weckbecker, I, Lewis, P, Schnieper, L J, Hofland, S W J, Lamberts
Publikováno v:
Journal of endocrinological investigation. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46665fd0e989d39c69b6cc257b3a8f67
https://pubmed.ncbi.nlm.nih.gov/15233205
https://pubmed.ncbi.nlm.nih.gov/15233205
Publikováno v:
Medicine. 73(5)
This prospective study defines the clinical and biochemical features of acromegaly in a large cohort of patients. There was no difference in sex distribution, and for men and women the mean ages at diagnosis (40 +/- 12 and 40 +/- 14 yr, respectively)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd805a5fe591f007c7e1148d7c6c7284
https://pubmed.ncbi.nlm.nih.gov/7934807
https://pubmed.ncbi.nlm.nih.gov/7934807
Publikováno v:
European Journal of Clinical Pharmacology. 31:127-131
The acute analgesic effect of single oral doses of 150 and 300 mg propyphenazone, 1000 mg acetylsalicylic acid (ASA) and placebo was investigated in 210 patients with pain following dental surgery. At most time points over the 3-hour observation peri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d5a56f3e2cb9364f84b6e16eb54667
https://doi.org/10.1007/bf00606648
https://doi.org/10.1007/bf00606648
Publikováno v:
Sandostatin® in the Treatment of Acromegaly ISBN: 9783642736964
Sandostatin® (SMS 201–995), a synthetic long-acting octapeptide, represents an efficacious alternative therapeutic candidate to available treatment modalities for acromegaly.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63344b597da09a6736dbe69778ea4a4
https://doi.org/10.1007/978-3-642-73694-0_17
https://doi.org/10.1007/978-3-642-73694-0_17
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.